Literature DB >> 17543248

Management of the cardiorenal syndrome in heart failure.

Jigar Patel1, J Thomas Heywood.   

Abstract

Heart failure treatment has seen great improvements in the past few decades. In many cases of heart failure, coexisting renal dysfunction, known as the cardiorenal syndrome, complicates treatment. Renal dysfunction is known to be a predictor of increased mortality. Renal dysfunction can be caused by various hemodynamic forces, medications, and intrinsic renal disease. With an understanding of the underlying etiology and physiology of the renal dysfunction, the appropriate treatment strategy can be planned. This understanding can also indicate when it is necessary to resort to therapies such as left ventricular assist device or dialysis. Such targeting of therapy can improve the prognosis of patients with heart failure and renal dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 17543248     DOI: 10.1007/s11886-006-0036-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  36 in total

Review 1.  The pathogenesis of vasodilatory shock.

Authors:  D W Landry; J A Oliver
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

Review 2.  Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

Authors:  Jan O Friedrich; Neill Adhikari; Margaret S Herridge; Joseph Beyene
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

3.  Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.

Authors:  Maria Rosa Costanzo; Mitchell Saltzberg; Jeanne O'Sullivan; Paul Sobotka
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

4.  Effect of increased renal venous pressure on renal function.

Authors:  W D BLAKE; R WEGRIA
Journal:  Am J Physiol       Date:  1949-04

5.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.

Authors:  M T Slawsky; W S Colucci; S S Gottlieb; B H Greenberg; E Haeusslein; J Hare; S Hutchins; C V Leier; T H LeJemtel; E Loh; J Nicklas; D Ogilby; B N Singh; W Smith
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

Review 7.  Chronic kidney disease: the global challenge.

Authors:  A Meguid El Nahas; Aminu K Bello
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

8.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

Authors:  H L Hillege; A R Girbes; P J de Kam; F Boomsma; D de Zeeuw; A Charlesworth; J R Hampton; D J van Veldhuisen
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

9.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

10.  Raised venous pressure: a direct cause of renal sodium retention in oedema?

Authors:  J D Firth; A E Raine; J G Ledingham
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

View more
  2 in total

1.  Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure.

Authors:  Sarah C Clayton; Karla K V Haack; Irving H Zucker
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-20

Review 2.  Systems biology and biomechanical model of heart failure.

Authors:  George E Louridas; Katerina G Lourida
Journal:  Curr Cardiol Rev       Date:  2012-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.